An observational study in Skin Microbiome and Undercast Materials, sponsored by BSN Medical GmbH. Completed at 3 sites in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-01-31.
Sponsored by BSN Medical GmbH · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This clinical study will evaluate the clinical performance and the safety of the CE-marked casting and padding materials when used in routine fracture care without any additional invasive methods and within the intended use. As primary objective the cast therapy´s influence on skin microbiome during fracture management will be investigated. Further, the influence of the padding material on the skin microbiome, device comfort, skin conditions, and impact on daily life activities as well as HCP´s and patient´s satisfaction and general product safety and performance are considered as secondary outcomes.
BSN Medical GmbH is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects with broken forwarm receiving short arm cast
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
will receive water resistante padding and a cast
Device: water resistante padding
will receive traditional non-water resistante padding and cast
Device: non water resistante padding
* Delta-Dry® Softliner * Tensoban® * Delta-Dry®
* Delta-Net® Stockinette * Delta-Rol®
products´ influence on skin microbiome during fracture management
Quantity of bacteria in the skin microbiome
Time frame: 3 weeks
products´ influence on skin microbiome during fracture management
Taxonomic composition of skin microbiome
Time frame: 3 weeks
products´ influence on skin microbiome during fracture management
Alpha diversity of skin microbiome
Time frame: 3 weeks
products´ influence on skin microbiome during fracture management
Beta diversity skin microbiome
Time frame: 3 weeks
Number of adverse events during study per product
Time frame: 3 weeks
General product performance
Time frame: 3 weeks
Treatment comfort
Time frame: 3 weeks
Impact on daily life activities
Time frame: 3 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Oct 2022 to primary completion in Sep 2024, 23 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
BSN Medical GmbH